Comparison of Minimal Residual Disease Detection between the Manual and Automated Gating Strategies of Euroflow Next-Generation Flow in Patients with Multiple Myeloma

被引：1
|
作者：
Takamatsu, Hiroyuki [1 ]
Yoroidaka, Takeshi [1 ,2 ]
Yamashita, Takeshi [2 ]
Murata, Ryoichi [2 ]
Ueda, Mikio [2 ]
Nakao, Shinji [1 ]
Matsue, Kosei [3 ]
机构：
[1] Kanazawa Univ, Dept Hematol, Kanazawa, Ishikawa, Japan
[2] Keiju Med Ctr, Dept Internal Med, Nanao, Japan
[3] Kameda Med Ctr, Div Hematol Oncol, Dept Med, Kamogawa, Japan
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-122398
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3083
引用
收藏
页数：3
相关论文
共 50 条
  • [21] A Comparison Between Next-Generation Sequencing and ASO-qPCR For Minimal Residual Disease Detection In Multiple Myeloma: The Clinical Value In ASCT Setting
    Takamatsu, Hiroyuki
    Mura, Ryoichi
    Zheng, Jianbiao
    Moorhead, Martin
    Yasushi, Terasaki
    Takashi, Yoshida
    Faham, Malek
    Nakao, Shinji
    BLOOD, 2013, 122 (21)
  • [22] A COMPARISON BETWEEN NEXT-GENERATION SEQUENCING AND ASO-QPCR FOR MINIMAL RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA: THE CLINICAL VALUE IN ASCT SETTING
    Takamatsu, H.
    Murata, R.
    Ito, S.
    Zheng, J.
    Moorhead, M.
    Terasaki, Y.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    HAEMATOLOGICA, 2014, 99 : 113 - 114
  • [23] Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy
    Terpos, Evangelos
    Kostopoulos, Ioannis, V
    Kastritis, Efstathios
    Ntanasis-Stathopoulos, Ioannis
    Migkou, Magdalini
    Rousakis, Pantelis
    Argyriou, Alexandra T.
    Kanellias, Nikolaos
    Fotiou, Despina
    Eleutherakis-Papaiakovou, Evangelos
    Gavriatopoulou, Maria
    Ziogas, Dimitrios C.
    Papanota, Aristea-Maria
    Spyropoulou-Vlachou, Marilyn
    Trougakos, Ioannis P.
    Tsitsilonis, Ourania E.
    Paiva, Bruno
    Dimopoulos, Meletios A.
    HEMASPHERE, 2019, 3 (06):
  • [24] Standardized minimal residual disease detection by next generation sequencing in multiple myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Chim, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E175 - E175
  • [25] Minimal Residual Disease in Autografts and Bone Marrow of Patients with Multiple Myeloma: 8-Color Multiparameter Flow Cytometry (EuroFlow- NGF) Vs. Next-Generation Sequencing
    Takamatsu, Hiroyuki
    Takezako, Naoki
    Yoroidaka, Takeshi
    Yamashita, Takeshi
    Murata, Ryoichi
    Yamazaki, Atsuko
    Takeuchi, Masahiro
    Mimura, Naoya
    Nakaseko, Chiaki
    Sakaida, Emiko
    Onoda, Masahiro
    Utsu, Yoshikazu
    Fukazawa, Motoharu
    Matsue, Kosei
    Nakao, Shinji
    BLOOD, 2020, 136
  • [26] Next Generation Flow (NGF) for High Sensitive Detection of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)
    Flores-Montero, Juan A.
    Paiva, Bruno
    Sanoja-Flores, Luzalba
    Puig, Noemi
    Garcia, Omar
    Boettcher, Sebastian
    Perez-Moran, Jose J.
    Belen Vidriales, Maria
    Mateos, Maria-Victoria
    Garcia-Sanz, Ramon
    Jimenez, Cristina
    Gonzalez, Marcos
    Martinez-Lopez, Joaquin
    Consuelo Canizo, Maria
    San Miguel, Jesus
    Durie, Brian
    van Dongen, Jacques J. M.
    Orfao, Alberto
    BLOOD, 2015, 126 (23)
  • [27] Prognostic implications of MRD assessment in multiple myeloma patients: comparison of Next-Generation Sequencing and Next-Generation Flow
    Medina, Alejandro
    Jimenez, Cristina
    Puig, Noemi
    Flores-Montero, Juan
    Paiva, Bruno
    Eugenia Sarasquete, M.
    Prieto-Conde, Isabel
    Garcia-Alvarez, Maria
    Chillon, Carmen
    Alcoceba, Miguel
    Gonzalez-Calle, Veronica
    Gutierrez, Norma C.
    de Arriba, Felipe
    Hernandez, Miguel T.
    Blade, Joan
    Martinez-Lopez, Joaquin
    Calasanz, Maria-Jose
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    San-Miguel, Jesus
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E47 - E47
  • [28] Minimal residual disease detection by next-generation sequencing in multiple myeloma: Promise and challenges for response-adapted therapy
    Ferla, Valeria
    Antonini, Elena
    Perini, Tommaso
    Farina, Francesca
    Masottini, Serena
    Malato, Simona
    Marktel, Sarah
    Stanghellini, Maria Teresa Lupo
    Tresoldi, Cristina
    Ciceri, Fabio
    Marcatti, Magda
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] The Value of PET/CT Combined with Next-Generation Flowcytometry in Minimal Residual Disease Detection and Prognostic Evaluation of Multiple Myeloma
    Du, Jianhua
    Chen, Miao
    Huo, Li
    Zhu, Wenjia
    Wang, Huijuan
    Leng, Yun
    Liu, Shuangjiao
    Zhuang, Junling
    BLOOD, 2022, 140 : 7214 - 7214
  • [30] COMPARISON BETWEEN 8-COLOR MULTIPARAMETER FLOW CYTOMETRY AND NEXT-GENERATION SEQUENCING TO DETECT MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PATIENTS WHO UNDERWENT AUTO-SCT
    Takamatsu, H.
    Wee, R.
    Takezako, N.
    Zheng, J.
    Carlton, V.
    Moorhead, M.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    HAEMATOLOGICA, 2016, 101 : 535 - 535
12345